ALLO vs AUTL: stock comparison and AI forecast
Allogene Therapeutics, Inc. (ALLO) and Autolus Therapeutics Plc (AUTL) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ALLO Allogene Therapeutics, Inc.
- Market Cap
- $387M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
AUTL Autolus Therapeutics Plc
- Market Cap
- $377M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ALLO and AUTL have similar market capitalizations ($387M and $377M).
- AUTL carries 2.37 times debt per unit of equity, against 0.26 times for ALLO.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ALLO | AUTL |
|---|---|---|
| Market Cap | $387M | $377M |
| P/B Ratio | 0.89x | 3.38x |
| EPS | $-0.77 | $-1.05 |
| Book Value/Share | $1.26 | $0.42 |
| Revenue/Share | – | $0.38 |
| FCF/Share | $-0.30 | $-0.87 |
Profitability & Margins
| Metric | ALLO | AUTL |
|---|---|---|
| ROE | -37.9% | – |
| ROA | -30.1% | – |
| ROIC | -34.8% | – |
| Gross Margin | – | 1.1% |
| Operating Margin | -3886.1% | – |
| Net Margin | -3566.7% | – |
| EBT Margin | -3489.0% | – |
| Tax Rate | – | -0.2% |
Financial Health
| Metric | ALLO | AUTL |
|---|---|---|
| Current Ratio | 10.72x | 4.89x |
| Quick Ratio | – | 4.40x |
| D/E Ratio | 0.26x | 2.37x |
| Financial Leverage | 1.26x | – |
| Interest Coverage | -6.6x | 16.4x |
| Working Capital | $308M | $267M |
Cash Flow
| Metric | ALLO | AUTL |
|---|---|---|
| Operating Cash Flow | -$102M | -$226M |
| Free Cash Flow | -$103M | -$233M |
| Capital Spending | -$400K | -$7M |
| FCF/Sales | – | -232.4% |
| CapEx/Sales | – | 7.1% |
Operational Efficiency
| Metric | ALLO | AUTL |
|---|---|---|
| Receivables Turnover | – | 2.3x |
| Inventory Turnover | – | 3.0x |
| Fixed Assets Turnover | – | 1.6x |
| Days Sales Outstanding | – | 162 days |
| Days Inventory | – | 123 days |
| Payables Period | – | 5 days |
| Cash Conversion Cycle | – | 280 days |
Income Statement
| Metric | ALLO | AUTL |
|---|---|---|
| Total Revenue | – | $100M |
| Operating Income | -$180M | -$247M |
| Net Income | -$165M | – |
| R&D Expense | $123M | $113M |
| SG&A Expense | – | $153M |
| Cost of Goods Sold | – | $99M |
Dividend & Shareholder Information
| Metric | ALLO | AUTL |
|---|---|---|
| Shares Outstanding | 345M | 266M |
ALLO vs AUTL: stock comparison and AI forecast
Which is bigger, ALLO or AUTL?
ALLO and AUTL have similar market capitalizations ($387M and $377M).
Which one does Intratio's AI model rank higher, ALLO or AUTL?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.